X chromosomal abnormalities in basal-like human breast cancer - Wikidata - awgldk - TriplyDB

X chromosomal abnormalities in basal-like human breast cancer

X chromosomal abnormalities in basal-like human breast cancer

http://www.wikidata.org/entity/Q28296876

about

GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7 MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium The atypical histone macroH2A1.2 interacts with HER-2 protein in cancer cells SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress Systematic discovery of nonobvious human disease models through orthologous phenotypes 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers Role of DeltaNp63gamma in epithelial to mesenchymal transition Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Triple negative breast cancer: looking for the missing link between biology and treatments PARP inhibitors in the management of breast cancer: current data and future prospects Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer Research advances of artemin The emergence of lncRNAs in cancer biology Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer Suppression of survival signalling pathways by the phosphatase PHLPP Utilization of genomic signatures to identify phenotype-specific drugs The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63 Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Re-sampling strategy to improve the estimation of number of null hypotheses in FDR control under strong correlation structures.BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin.A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genes Identifying network biomarkers based on protein-protein interactions and expression data.The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers.Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.Common human cancer genes discovered by integrated gene-expression analysis.

P2860

Q21560759-5FF99024-EDBD-4D1C-96B9-DD827E3177C1 Q21560948-50008D40-7573-4B79-B558-A5D801C51F8F Q24303562-B02083CD-C00B-47ED-AFA4-7947934C7DB6 Q24304338-B4B2D90E-1DD6-4E92-81E7-BCDC1A6EDF1C Q24309483-F8362C00-5F67-4B2B-A19F-0127C4EC32EE Q24310299-4A42B51B-DE79-4501-9E62-BA360AD8DA92 Q24313363-ACD023EF-3C15-4418-8F24-01D0051F0DB7 Q24313524-61C9FD1A-D278-4067-A6E0-B1DB45BA086F Q24314897-3469999E-BD31-4552-AB5C-A4F14A6AF8CE Q24316768-7A340B31-4F2E-489C-AACB-F15143948B4C Q24318278-4DB586BB-2F41-4E27-8E66-CA8116243E70 Q24322930-08BCAB98-BC1F-4042-900E-50A2AD56D98C Q24599420-6F558081-E5AE-41CC-9F10-0D3684B64990 Q24600277-61EA346F-E2FC-4F39-88D6-F9AB8756E101 Q24600350-11BCD8B8-9E0C-4F70-A4B4-44F9D0C913CE Q24632945-6ABBD99F-206B-4732-BC3B-B069941C64FB Q24644185-1057D615-10C1-4A80-A222-F7D0A037853C Q24646090-943FC604-1EC7-408A-9AA9-246FBC9942CE Q24674085-B075DF3F-D5CD-45E3-81A7-8311BF1F3A8D Q26783122-3C822D14-5E7C-4EA4-B068-7D821335EF5C Q26798352-8A4C97A6-6977-40F8-88C8-0CB9C7879149 Q26849813-8C71DC47-122C-4EDE-A7B7-A1E7268942A4 Q26992299-8DB188D0-688A-4244-BF6A-4ACCF9135678 Q27024237-4FA68BAE-2810-4A03-A14D-C0AAF5E2EEFB Q27025623-44FDC4A3-B8D3-48BA-AD91-4A95E90393D8 Q28273187-195A44C6-8FEC-4EB6-B426-D689D3E9B53F Q28295895-4BD86BAB-8876-4787-87E3-4C550C0FC8FA Q28372484-C572AF69-E9A0-44A9-BFD3-2863170E7C5F Q28388451-CC31AE63-94F0-4D2A-BA59-03AC86684082 Q28476014-9E5E3241-C560-4BC0-B239-E49AC129C900 Q28507014-19422500-66CB-4B81-85FE-9AA58EA5853E Q28589378-9D040C72-BCFF-422B-941B-7A4C3998A01D Q29617680-C9CC4C88-BB3E-4F94-A5BC-E9495488DB69 Q30479567-C904E915-3CA2-4934-B1CE-CB22B466D2E8 Q30480563-879AC6BD-7093-4490-99B9-B00960B22219 Q30566202-16BB00B0-00D7-4F15-B2FE-44C5C9281822 Q30965908-7E91ECDD-C2BD-4EB3-9902-363A2627D3FB Q30992805-F37DEFC0-B201-443F-886E-149D88AD24A8 Q33275880-15F29066-FAE4-4165-AAD7-170BBC928A3B Q33305350-ECADA582-9BD9-4B57-B4AC-B8EC26B368FD

P2860

X chromosomal abnormalities in basal-like human breast cancer

http://www.wikidata.org/entity/Q28296876

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

X chromosomal abnormalities in basal-like human breast cancer

@ast

X chromosomal abnormalities in basal-like human breast cancer

@en

X chromosomal abnormalities in basal-like human breast cancer

@nl

type

label

X chromosomal abnormalities in basal-like human breast cancer

@ast

X chromosomal abnormalities in basal-like human breast cancer

@en

X chromosomal abnormalities in basal-like human breast cancer

@nl

prefLabel

X chromosomal abnormalities in basal-like human breast cancer

@ast

X chromosomal abnormalities in basal-like human breast cancer

@en

X chromosomal abnormalities in basal-like human breast cancer

@nl

P1433

Q28296876-7917AE6F-EFB0-4A7C-A0B6-724FB6EFA984

P1476

Q28296876-884F2F4A-26FB-499F-A120-67D22E2E0CC7

P2093

Q28296876-1143A6C1-F9BE-45AF-8AC0-CC0B16D83141

Q28296876-24988E36-E4BE-4EF3-999D-484D3438D4ED

Q28296876-362212AD-5795-427A-B3C1-CDFA932402DA

Q28296876-3D596E2E-2422-4A0F-BD39-3FF52676E025

Q28296876-3E9DB473-7393-41C4-BA53-45B8FBEBF880

Q28296876-4DD526DA-8F24-4D26-A7DD-25372F98B4F7

Q28296876-5B63CEA1-9118-46EA-A6FF-3666A61DEE04

Q28296876-6D20AC5B-55E6-4AE1-BA51-C7A48CF3D79D

Q28296876-83D52EA9-B956-4687-95DA-5B38FD359964

P304

Q28296876-6B90724C-26E4-436A-8456-1A26BEE48551

P31

Q28296876-CF1CFD1B-7058-444D-A24B-C6A122522CB0

P3181

Q28296876-AEA9A75F-AC82-4163-8986-F90BE59C8C58

P356

Q28296876-891B4D2C-929D-4055-9B11-0E26BC16F576

P407

Q28296876-5609B33A-373A-48B8-BB0F-5283612B52BB

P433

Q28296876-A2B80DDF-0BE9-4C6D-AFB1-79DA0B95262B

P478

Q28296876-2A780DD6-E58B-4205-9CB8-01BC8FD5ACED

P50

Q28296876-32DBEAA3-8F94-45E3-8C84-14EB1592D025

P577

Q28296876-C7BD9EAD-1DD9-48E0-976E-8265CE77F63F

P5875

Q28296876-2FF42420-1085-4F91-BBBE-51ECEB8E2C2C

P698

Q28296876-4BFE6E6A-51CB-4B17-92D4-04125E92FC61

P3181

P356

J.CCR.2006.01.013

P1433

P1476

X chromosomal abnormalities in basal-like human breast cancer

@en

P2093

Alexander Miron

http://www.w3.org/2001/XMLSchema#string

Andrea L Richardson

http://www.w3.org/2001/XMLSchema#string

Arcangela De Nicolo

http://www.w3.org/2001/XMLSchema#string

David M Livingston

http://www.w3.org/2001/XMLSchema#string

J Dirk Iglehart

http://www.w3.org/2001/XMLSchema#string

Shridar Ganesan

http://www.w3.org/2001/XMLSchema#string

Xiaodong Liao

http://www.w3.org/2001/XMLSchema#string

Xin Lu

http://www.w3.org/2001/XMLSchema#string

Zhigang C Wang

http://www.w3.org/2001/XMLSchema#string

P304

121-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1070135

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CCR.2006.01.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7303846

http://www.w3.org/2001/XMLSchema#string

P698

16473279

http://www.w3.org/2001/XMLSchema#string